Commonwealth Equity Services’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-847
| Closed | -$8K | – | 3981 |
|
|
2023
Q3 | $8K | Sell |
847
-6
| -0.7% | -$57 | ﹤0.01% | 3789 |
|
|
2023
Q2 | $7K | Sell |
853
-307
| -26% | -$2.52K | ﹤0.01% | 3801 |
|
|
2023
Q1 | $12 | Sell |
1,160
-4
| -0.3% | – | ﹤0.01% | 3712 |
|
|
2022
Q4 | $39K | Sell |
1,164
-220
| -16% | -$7.37K | ﹤0.01% | 3536 |
|
|
2022
Q3 | $66K | Sell |
1,384
-3
| -0.2% | -$143 | ﹤0.01% | 3442 |
|
|
2022
Q2 | $79K | Sell |
1,387
-180
| -11% | -$10.3K | ﹤0.01% | 3416 |
|
|
2022
Q1 | $126K | Sell |
1,567
-30
| -2% | -$2.41K | ﹤0.01% | 3439 |
|
|
2021
Q4 | $323K | Sell |
1,597
-415
| -21% | -$83.9K | ﹤0.01% | 2903 |
|
|
2021
Q3 | $541K | Buy |
2,012
+248
| +14% | +$66.7K | ﹤0.01% | 2414 |
|
|
2021
Q2 | $453K | Buy |
1,764
+16
| +0.9% | +$4.11K | ﹤0.01% | 2543 |
|
|
2021
Q1 | $524K | Buy |
1,748
+65
| +4% | +$19.5K | ﹤0.01% | 2297 |
|
|
2020
Q4 | $429K | Sell |
1,683
-29
| -2% | -$7.39K | ﹤0.01% | 2262 |
|
|
2020
Q3 | $425K | Sell |
1,712
-117
| -6% | -$29K | ﹤0.01% | 2078 |
|
|
2020
Q2 | $635K | Buy |
1,829
+56
| +3% | +$19.4K | ﹤0.01% | 1721 |
|
|
2020
Q1 | $474K | Sell |
1,773
-84
| -5% | -$22.5K | ﹤0.01% | 1730 |
|
|
2019
Q4 | $601K | Sell |
1,857
-202
| -10% | -$65.4K | ﹤0.01% | 1761 |
|
|
2019
Q3 | $562K | Buy |
2,059
+271
| +15% | +$74K | ﹤0.01% | 1738 |
|
|
2019
Q2 | $954K | Buy |
1,788
+183
| +11% | +$97.6K | ﹤0.01% | 1372 |
|
|
2019
Q1 | $808K | Buy |
1,605
+393
| +32% | +$198K | ﹤0.01% | 1440 |
|
|
2018
Q4 | $597K | Buy |
1,212
+124
| +11% | +$61.1K | ﹤0.01% | 1518 |
|
|
2018
Q3 | $994K | Buy |
1,088
+191
| +21% | +$174K | ﹤0.01% | 1304 |
|
|
2018
Q2 | $657K | Buy |
897
+297
| +50% | +$218K | ﹤0.01% | 1568 |
|
|
2018
Q1 | $956K | Buy |
600
+237
| +65% | +$378K | 0.01% | 1283 |
|
|
2017
Q4 | $325K | Buy |
+363
| New | +$325K | ﹤0.01% | 1995 |
|